Evolent Health, Inc.
EVH· NYSE
Released May 7, 2020, after the close
10-Q filed May 28, 2020, 58 days after period end · 0001628908-20-000068
| Metric | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 |
|---|---|---|---|---|
| Revenue | $247.29M | $197.76M | $139.71M | $106.24M |
| Net Income | -$78.75M | -$46.74M | -$13.63M | -$18.01M |
| EPS Diluted |
Evolent Health, Inc. · CIK 1628908 · Engraved from SEC EDGAR
| -$0.93 |
| -$0.59 |
| -$0.18 |
| -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.